1. Blood DNA methylation patterns in older adults with evolving dementia
- Author
-
Pérez, Raúl Fernández, Alba-Linares, Juan José, Tejedor, Juan Ramón, Fernández, Agustín Fernández, Calero, Miguel, Román-Domínguez, Aurora, Borrás, Consuelo, Viña, José, Ávila, Jesús, Medina, Miguel, Fraga, Mario Fernández, Fernández, Agustín, Asociación Española Contra el Cáncer, Gobierno del Principado de Asturias (España), Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF), Fundación General (CSIC), Instituto de Salud Carlos III, Plan Nacional de I+D+i (España), Ministerio de Ciencia e Innovación (España), Instituto Universitario de Oncología del Principado de Asturias, Fundación Cajastur, Instituto de Investigación Sanitaria del Principado de Asturias (España), Centro de Investigación Biomédica en Red - CIBERER (Enfermedades Raras), Principado de Asturias, European Commission, Fundación General CSIC, Ministerio de Economía y Competitividad (España), Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Instituto de Investigación Sanitaria del Principado de Asturias, Obra Social Cajastur, and Liberbank
- Subjects
Epigenomics ,Aging ,DNA methylation ,Epigenetic age ,Aryldialkylphosphatase ,Cognitive decline ,DNA Methylation ,Epigenesis, Genetic ,Humans ,Dementia ,Epigenetics ,Geriatrics and Gerontology ,Adaptor Proteins, Signal Transducing ,Aged - Abstract
Dementia and cognitive disorders are major aging-associated pathologies. The prevalence and severity of these conditions are influenced by both genetic and environmental factors. Reflecting this, epigenetic alterations have been associated with each of these processes, especially at the level of DNA methylation, and such changes may help explain the observed interindividual variability in the development of the 2 pathologies. However, the importance of epigenetic alterations in explaining their etiology is unclear because little is known about the timing of when they appear. Here, using Illumina MethylationEPIC arrays, we have longitudinally analyzed the peripheral blood methylomes of cognitively healthy older adults (>70 year), some of whom went on to develop dementia while others stayed healthy. We have characterized 34 individuals at the prediagnosis stage and at a 4-year follow-up in the postdiagnosis stage (total n = 68). Our results show multiple DNA methylation alterations linked to dementia status, particularly at the level of differentially methylated regions. These loci are associated with several dementia-related genes, including PON1, AP2A2, MAGI2, POT1, ITGAX, PACSIN1, SLC2A8, and EIF4E. We also provide validation of the previously reported epigenetic alteration of HOXB6 and PM20D1. Importantly, we show that most of these regions are already altered in the prediagnosis stage of individuals who go on to develop dementia. In conclusion, our observations suggest that dementia-associated epigenetic patterns that have specific biological features are already present before diagnosis, and thus may be important in the design of epigenetic biomarkers for disease detection based on peripheral tissues., This work was supported by: the Spanish Association Against Cancer (grant number PROYE18061FERN to M.F.F.), the Asturias Government (PCTI) cofunding 2018-2022/FEDER (grant number IDI/2018/146 to M.F.F.), the Fundación General CSIC (grant number 0348_CIE_6_E to M.F.F.) and the Health Institute Carlos III (Plan Nacional de I + D + I) cofunding FEDER (grant numbers PI15/00892, PI18/01527 to M.F.F. and A.F.F.). JRT is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation (grant number FJCI-2015-26965). R.F.P. is supported by the Severo Ochoa program (grant number BP17-114). We also acknowledge support from the Institute of Oncology of Asturias (IUOPA, supported by Obra Social Cajastur Liberbank, Spain), the Health Research Institute of Asturias (ISPA-FINBA) and Consorcio Centro de Investigación Biomédica en Red (CIBERER-ISCIII).
- Published
- 2022